香雪品牌怎么样 申请店铺

我要投票 香雪在中草药行业中的票数:12 更新时间:2024-11-22
香雪是哪个国家的品牌?「香雪」是 广州市香雪制药股份有限公司 旗下著名品牌。该品牌发源于广东,由创始人王永辉在1986期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
香雪怎么样

广州市香雪制药股份有限公司总部位于广州经济技术开发区科学城,是一家以中成药制药和研发为主业,集西药制药、生物医学工程和药材规范种植于一体的现代化高新技术医药企业。

公司秉承“厚生臻善维新”的企业理念,坚持“崇尚品质;关爱健康”的质量方针,坚持自主创新、自主品牌,在品质、技术、研发、品牌和规模等多方面成长为行业领先者,得到消费者、行业和政府主管部门的高度评价和广泛认可,其中“香雪”商标获评中国驰名商标,“香雪抗病毒口服液”获评广东省名牌和广州市名牌产品,香雪制药获评“《福布斯》中国成长企业潜力榜100强”前五位,香雪制药获评“广东省医药产业50强企业”和“广州2010年亚运会药品供应商”等。

香雪制药一直致力于质量创新,致力于中药现代化的研究和实践,1998年开始进行中药现代化关键技术指纹图谱质量控制技术的研究,并取得重大突破。2001年,香雪抗病毒口服液指纹图谱质控研究被纳入广州名优中成药品种指纹图谱质量控制示范研究项目。2000年,香雪制药本着“实施中药系列标准规范,提高中成药品种质量”的理念,承担了国家科技部的“九五”重点科技攻关项目广藿香GAP种植基地,经过一年多的探索与研究,现已被国家科技部列入第一批国家中药现代化科技产业化(广东)基地,并通过国家验收。

香雪制药本着高起点、高技术、高标准、高速度的现代企业发展战略,采用先进的技术、工艺、设备,形成了完善、科学、先进的生产体系,使公司的产品质量和主要技术指标均达到了国内先进水平。公司坚持“创新”为企业的灵魂,以科技进步推动企业的发展。近年来承担了多项国家及省、市级重大科技专项技术的研究与开发;本着生产一代、储备一代、研制一代、构思一代的新产品开发战略。加快了疗效确切、科技含量高的新产品的研制开发。

Guangzhou Xiangxue Pharmaceutical Co., Ltd., headquartered in Science City, Guangzhou Economic and Technological Development Zone, is a modern high-tech pharmaceutical enterprise with Chinese patent medicine and R & D as its main business, integrating western medicine, biomedical engineering and standard planting of medicinal materials. The company adheres to the enterprise concept of "great life, perfect and innovative", and adheres to "advocating quality"; The company adheres to the quality policy of "care for health", adheres to independent innovation and independent brand, grows into the industry leader in quality, technology, R & D, brand and scale, and is highly appraised and widely recognized by consumers, industry and government authorities. Among them, "Xiangxue" trademark is awarded the famous trademark in China, and "Xiangxue antiviral oral liquid" is awarded the famous brand in Guangdong Province and Guangzhou city Brand products, Xiangxue pharmaceutical won the top five "Forbes China growth enterprise potential list top 100", Xiangxue pharmaceutical won the "top 50 pharmaceutical enterprises in Guangdong Province" and "drug supplier of Guangzhou 2010 Asian Games" and so on. Xiangxue pharmaceutical has been committed to quality innovation, research and practice of the modernization of traditional Chinese medicine. In 1998, it began to study the key technology of the modernization of traditional Chinese medicine fingerprint quality control technology, and made a major breakthrough. In 2001, the fingerprint quality control research of Xiangxue antiviral oral liquid was included in the quality control demonstration research project of Guangzhou famous and excellent Chinese patent medicine. In 2000, in line with the concept of "implementing the standards and specifications of traditional Chinese medicine series and improving the quality of traditional Chinese medicine varieties", Xiangxue pharmaceutical undertook the patchouli gap planting base, a key scientific and technological key project of the Ninth Five Year Plan of the Ministry of science and technology of the people's Republic of China. After more than a year's exploration and research, it has been listed in the first batch of national bases for the modernization of science and technology industrialization of traditional Chinese medicine (Guangdong) by the Ministry of science and technology of the people's Republic of China and passed the national acceptance 。 Based on the modern enterprise development strategy of high starting point, high technology, high standard and high speed, Xiangxue pharmaceutical adopts advanced technology, process and equipment to form a perfect, scientific and advanced production system, so that the product quality and main technical indicators of the company have reached the advanced level in China. The company adheres to "innovation" as the soul of the enterprise and promotes the development of the enterprise with the progress of science and technology. In recent years, it has undertaken the research and development of a number of national, provincial and municipal major science and technology special technologies; in line with the new product development strategy of production generation, storage generation, development generation and conception generation. The research and development of new products with precise curative effect and high technology content are accelerated.

本文链接: https://brand.waitui.com/f0447df2d.html 联系电话:020-22211555

千城特选小程序码

7×24h 快讯

李彦宏:百度文库AI功能月活用户超5000万,同比增长超300%

36氪获悉,百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏披露,今年9月,百度文库AI功能月活用户突破5000万,同比增长超300%。此外,用户的付费意愿不断增强,第三季度文库的订阅收入同比增长23%。在近期举办的百度世界2024上,百度文库与百度网盘联合推出了工具类智能体“自由画布”,亮相首日即吸引超20万人排队预约。

20分钟前

李彦宏:Q3智能云营收快速增长,AI收入占比提升至超11%

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏公布,三季度,百度智能云营收达49亿元,同比增长11 %,Non-GAAP 经营利润率同比提升。其中,AI相关收入占比持续提升至超11%。据IDC报告,在中国AI公有云市场,百度智能云已连续五年位居第一。

20分钟前

热门中概股美股盘前普跌,拼多多跌超10%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超10%,小鹏汽车、爱奇艺跌超4%,百度、B站跌超2%,蔚来跌超1%。

20分钟前

我国载人登月任务已全面进入初样研制阶段

中国载人航天工程总设计师周建平21日在深圳召开的第六届载人航天学术大会上表示,我国载人月球探测工程载人登月任务已经完成了前期的关键技术攻关和深化论证,目前全面进入了初样研制阶段。“目前,长征十号运载火箭、梦舟载人飞船、揽月月面着陆器、载人月球车等初样产品正在紧张研制过程中。不少初样产品已经研制出来,正在进行相关测试。”周建平说。(新华社)

20分钟前

李彦宏:百度将于2025年初发布新版大模型

36氪获悉,在百度2024年第三季度财报电话会上,百度创始人、董事长兼首席执行官李彦宏透露,百度将于2025年初发布文心大模型的新版本,以巩固在基础模型上的领先优势。李彦宏表示,11月,文心大模型日均调用量达15亿,日均处理Tokens文本超1.7万亿。相较一年前首次披露的5000万次日均调用量,增长30倍。

20分钟前

本页详细列出关于百灵鸟的品牌信息,含品牌所属公司介绍,百灵鸟所处行业的品牌地位及优势。
咨询